Top Cancer Stocks in Australia
Browse the largest Australia companies in the world ranked by their Market Capitalization. Global Cancer Companies in Australia market cap is $4.87B.
3 Sept 2024, 20:18 UTC
Companies: 11
🇦🇺1 |  | $12.23 | -2.85% | 3.96B | 79.01% | Outperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇦🇺2 |  | $0.05 | 9.68% | 290.71M | -38.18% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇦🇺3 |  | $0.26 | -3.70% | 235.51M | 11.43% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇦🇺4 |  | $0.10 | 3.57% | 70.01M | 20.83% | Outperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇦🇺5 |  | $0.13 | 0.00% | 41.39M | 65.22% | Outperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇦🇺6 |  | $0.38 | -0.89% | 34.56M | -17.78% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇦🇺7 |  | $0.06 | 0.00% | 18.98M | 29.73% | Outperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇦🇺8 |  | $0.01 | 0.00% | 16.08M | 33.33% | Outperform S&P500 YTD Benchamark | 🩹 Medical devices | - |
🇦🇺9 |  | $0.02 | 2.94% | 15.57M | 75.00% | Outperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇦🇺10 |  | $0.00 | 0.00% | 13.03M | -40.00% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇦🇺11 |  | $0.00 | -14.29% | 8.37M | -25.00% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
